Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Melanoma Research|November 10, 2021
Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanomaVasu R Sah, Joakim Karlsson, Henrik Jespersen, et al.
Pharmaceuticals (Basel, Switzerland)|December 22, 2019
Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1ACorinne Fruit, Florence Couly, Rahul Bhansali, et al.
Journal of Clinical Nursing|April 5, 2013
Pain characteristics and self-rated health after elective orthopaedic surgery - a cross-sectional surveyMaren F Lindberg, Ellen K Grov, Caryl L Gay, et al.
Journal of Medicinal Chemistry|July 24, 2023
Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine BEmmanuel Deau, Mattias F Lindberg, Frédéric Miege, et al.
Organic & Biomolecular Chemistry|February 2, 2012
Lipothiophosphoramidates for gene delivery: critical role of the cationic polar headgroupAurore Fraix, Tristan Montier, Tony Le Gall, et al.
Postgraduate Medicine|September 15, 1986
Thromboembolism after hip surgery. Comparison of screening methodsM M Mitsunaga, E B Ferris, A Y Kong, et al.
The Journal of Trauma|June 1, 1985
Thromboembolism following hip fractureJ S Montrey, R L Kistner, A Y Kong, et al.
The Journal of Prevention of Alzheimer'S Disease|July 16, 2022
Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD RatsB Souchet, M Audrain, Y Gu, et al.
Pageof 10